Abnormal thyroid function in older men with or at risk for HIV infection

HIV Medicine

Volumn 9, Issue 7, 2008, Pages 544-549

  Wiener, M ^a   Lo, Y ^b   Klein, Robert S ^b,c  

^a NORTH GENERAL HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

Endocrine; Epidemiology; Thyroid function tests; Thyroid hormones; Thyroid stimulating hormone

Indexed keywords

COCAINE; DIAMORPHINE; HEPATITIS C ANTIBODY; INTERFERON; LIOTHYRONINE; PROTEINASE INHIBITOR; THYROID HORMONE; THYROTROPIN; THYROXINE; VIRUS RNA;

ADULT; AFRICAN AMERICAN; AGED; ARTICLE; BODY MASS; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTHYROIDISM; HYPOTHYROIDISM; INFECTION RISK; INTERVIEW; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; THYROID DISEASE; VIRUS LOAD;

AGED; BODY MASS INDEX; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; HEPATITIS C ANTIBODIES; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; LOGISTIC MODELS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; RNA, VIRAL; THYROTROPIN; VIRAL LOAD;

EID: 50149095420     PISSN: 14642662     EISSN: 14681293     Source Type: Journal    
DOI: 10.1111/j.1468-1293.2008.00601.x     Document Type: Article

References (20)

1. Palella FJ Jr., Delaney KM, Moorman AC et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860.
2. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 2005; 17: 5-47.
3. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab 2002; 87: 489-499.
4. Vanderpump MPJ. The epidemiology of thyroid disease, In: Braverman LE, Utiger RD, eds. Werner and Ingbar's the Thyroid: A Fundamental and Clinical Text. Philadelphia, PA: Lippincott Williams and Wilkins, 2005.
5. Arnsten JH, Freeman R, Howard AA, Floris-Moore M, Lo Y, Klein RS. Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS 2007; 21: 617-623.
6. Casau NC. Perspective on HIV infection and aging: Emerging research on the horizon. Clin Infect Dis 2005; 41: 855-863.
7. Friis-Moller N, Sabin CA, Weber R et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 2003; 349: 1993-2003.
8. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado Thyroid Disease Prevalence Study. Arch Intern Med 2000; 160: 526-534.
9. Hirschfeld S, Laue L, Cutler GB Jr., Pizzo PA. Thyroid abnormalities in children infected with human immunodeficiency virus. J Pediatr 1996; 128: 70-74.
10. LoPresti JS, Fried JC, Spencer CA, Nicoloff JT. Unique alterations of thyroid hormone indices in the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 110: 970-975.
11. Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005; 41: 1794-1803.
12. Lambert M, Zech F, De Nayer P, Jamez J, Vandercam B. Elevation of serum thyroxine-binding globulin (but not of cortisol-binding globulin and sex hormone-binding globulin) associated with the progression of human immunodeficiency virus infection. Am J Med 1990; 89: 748-751.
13. Calza L, Manfredi R, Chiodo F. Subclinical hypothyroidism in HIV-infected patients receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2002; 31: 361-363.
14. Collazos J, Ibarra S, Mayo J. Thyroid hormones in HIV-infected patients in the highly active antiretroviral therapy era: Evidence of an interrelation between the thyroid axis and the immune system. AIDS 2003; 17: 763-765.
15. Beltran S, Lescure FX, Desailloud R et al. Increased prevalence of hypothyroidism among human immunodeficiency virus-infected patients: A need for screening. Clin Infect Dis 2003; 37: 579-583.
16. Grappin M, Piroth L, Verges B et al. Increased prevalence of subclinical hypothyroidism in HIV patients treated with highly active antiretroviral therapy. AIDS 2000; 14: 1070-1072.
17. Madeddu G, Spanu A, Chessa F et al. Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): A longitudinal study. Clin Endocrinol (Oxford) 2006; 64: 375-383.
18. Hoffman CJ, Brown TT. Thyroid function abnormalities in HIV-infected patients. Clin Infect Dis 2007; 45: 488-494.
19. Klein RS, Lo Y, Santoro N, Dobs AS. Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis 2005; 41: 1794-1803.
20. Surks MI, Ortiz E, Daniels GH et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291: 228-238.